inTRAvent Medical Partners

inTRAvent Medical Partners is a private U.S. medical technology company developing bedside neurosurgical navigation systems for neurocritical care. The company commercializes the SOLOPASS platform, a portable image-guided system that uses 2D and 3D ultrasound imaging, artificial intelligence, and trajectory guidance to aid frontal placement of intraventricular catheters and external ventricular drains. The technology originated from work at Penn State Hershey Medical Center and is designed to bring intra-operative imaging and navigation capabilities to the bedside rather than relying on conventional operating-room workflows. inTRAvent has received FDA 510(k) clearance for both the original SOLOPASS System and the next-generation SOLOPASS 2.0 System, positioning the company as a focused neurosurgical device developer rather than a therapeutics company.